BG34463A3 - Метод за получаване на инхибитор на превръщащия ангиотенизина ензим - Google Patents

Метод за получаване на инхибитор на превръщащия ангиотенизина ензим

Info

Publication number
BG34463A3
BG34463A3 BG044830A BG4483079A BG34463A3 BG 34463 A3 BG34463 A3 BG 34463A3 BG 044830 A BG044830 A BG 044830A BG 4483079 A BG4483079 A BG 4483079A BG 34463 A3 BG34463 A3 BG 34463A3
Authority
BG
Bulgaria
Prior art keywords
inhibitor
angiotensine
enzym
conversion
obtaining
Prior art date
Application number
BG044830A
Other languages
English (en)
Inventor
Janes Ryan
Alfred Chung
Original Assignee
University Of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/064,898 external-priority patent/US4690938A/en
Priority claimed from US06/064,902 external-priority patent/US4690940A/en
Priority claimed from US06/064,901 external-priority patent/US4695577A/en
Priority claimed from US06/064,900 external-priority patent/US4690939A/en
Priority claimed from US06/064,903 external-priority patent/US4698355A/en
Priority claimed from US06/064,897 external-priority patent/US4690937A/en
Priority claimed from US06/064,899 external-priority patent/US4698356A/en
Application filed by University Of Miami filed Critical University Of Miami
Publication of BG34463A3 publication Critical patent/BG34463A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Метод за получаване на инхибитор на превръщащия ангиотензина ензим с формула.......... Патентните претенции са формулирани в 10 точки
BG044830A 1978-09-11 1979-09-11 Метод за получаване на инхибитор на превръщащия ангиотенизина ензим BG34463A3 (bg)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US94128978A 1978-09-11 1978-09-11
US95818078A 1978-11-06 1978-11-06
US06/064,898 US4690938A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,902 US4690940A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,901 US4695577A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,900 US4690939A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,903 US4698355A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,897 US4690937A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,899 US4698356A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents

Publications (1)

Publication Number Publication Date
BG34463A3 true BG34463A3 (bg) 1983-09-15

Family

ID=27578299

Family Applications (1)

Application Number Title Priority Date Filing Date
BG044830A BG34463A3 (bg) 1978-09-11 1979-09-11 Метод за получаване на инхибитор на превръщащия ангиотенизина ензим

Country Status (15)

Country Link
EP (1) EP0009898B1 (bg)
AT (1) AT390795B (bg)
AU (1) AU532424B2 (bg)
BG (1) BG34463A3 (bg)
CS (1) CS242857B2 (bg)
DE (1) DE2965443D1 (bg)
DK (1) DK376179A (bg)
FI (1) FI71749C (bg)
GR (1) GR73585B (bg)
HU (1) HU187258B (bg)
IL (1) IL58223A (bg)
IT (1) IT1193214B (bg)
NZ (1) NZ191524A (bg)
PH (1) PH19104A (bg)
PT (1) PT70158A (bg)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
PT70158A1 (en) * 1980-03-03 1982-03-01 Univ Miami Process for preparing anti-hypertensive agents
US4734420A (en) * 1980-03-05 1988-03-29 University Of Miami Anti-hypertensive agents
US4690936A (en) * 1980-03-05 1987-09-01 University Of Miami Anti-hypertensive agents
EP0036713B1 (en) * 1980-03-05 1984-01-18 University Of Miami Angiotensin converting enzyme inhibitors
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4512979A (en) * 1981-03-23 1985-04-23 Merck & Co., Inc. Dipeptides containing thialysine and related amino acids as antihypertensives
JPS57209270A (en) * 1981-06-19 1982-12-22 Chugai Pharmaceut Co Ltd Proline derivative
AT386603B (de) * 1981-06-19 1988-09-26 Chugai Pharmaceutical Co Ltd Verfahren zur herstellung von neuen prolinderivaten
HUT46044A (en) * 1986-11-21 1988-09-28 Richter Gedeon Vegyeszet Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
CN1081650C (zh) * 1995-12-27 2002-03-27 罗纳-普朗克·维斯科苏希公司 缩聚物,尤其是聚酰胺6,6后冷凝的方法
ES2424332T3 (es) 2008-06-14 2013-10-01 Veredus Laboratories Pte Ltd Secuencias de la gripe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
US4116962A (en) * 1976-12-03 1978-09-26 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
US4091024A (en) * 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4108886A (en) * 1977-03-11 1978-08-22 E. R. Squibb & Sons, Inc. Thiopropanoylamino acid derivatives

Also Published As

Publication number Publication date
EP0009898A1 (en) 1980-04-16
FI71749B (fi) 1986-10-31
GR73585B (bg) 1984-03-26
NZ191524A (en) 1982-12-07
IL58223A (en) 1984-01-31
DE2965443D1 (en) 1983-07-07
CS615079A2 (en) 1985-08-15
PH19104A (en) 1986-01-02
IT1193214B (it) 1988-06-15
IT7925612A0 (it) 1979-09-11
ATA596279A (de) 1989-12-15
CS242857B2 (en) 1986-05-15
AU5070579A (en) 1980-03-20
AU532424B2 (en) 1983-09-29
FI792806A (fi) 1980-03-12
EP0009898B1 (en) 1983-05-18
AT390795B (de) 1990-06-25
DK376179A (da) 1980-03-12
HU187258B (en) 1985-12-28
PT70158A (en) 1979-09-30
FI71749C (fi) 1987-02-09

Similar Documents

Publication Publication Date Title
BG28708A3 (bg) Метод за получаване на имидазолови производни
BG31497A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортонизамиди
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG33286A3 (bg) Метод за получаване на нови 4-хидрокси-2н-1,2 -бензотиазин-3-карбоксамид-1,1-двуориси,тяхната употреба и съдържащи тези съединения лекарствени средства
BG31645A3 (bg) Метод за получаване на фенетаноламини
BG31799A3 (bg) Метод за получаване на хидантоини
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG29281A3 (bg) Метод за получаване на 1-(р-метоксибензоил)-2-пиролидинон
BG33294A3 (bg) Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG31946A4 (bg) Метод за получаване на 4-ациламино-фенил- етаноламини
BG34463A3 (bg) Метод за получаване на инхибитор на превръщащия ангиотенизина ензим
ES482598A1 (es) Un procedimiento para la preparacion de n-(diaminofosfinil) aril-carboxamidas.
BG32853A3 (bg) Метод за получаване на 1- оксадетиацефалоспорини
BG31070A3 (bg) Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини
ES460204A1 (es) Un procedimiento para la preparacion de acidos ureido(susti-tuidos) acetohidroxamicos.
BG30175A4 (bg) Метод за получаване на пиридонови съединения
BG28574A3 (bg) Метод за получаване на 4 дифенилметилен 1 хидрокси бензол пиперидини
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG35897A3 (bg) Метод за получаване на 5-(дихидрокси-фенокси)-1н-тетразоли
BG32117A4 (bg) Метод за получаване олеандомицини
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони
BG30174A4 (bg) Метод за получаване на бензоилкарбамиди
BG31947A3 (bg) Метод за получаване на ацетидинови производни
BG34459A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
BG29283A3 (bg) Метод за получаване на имидазолови производни